Literature DB >> 21562214

Systematic identification of immunodominant CD8+ T-cell responses to influenza A virus in HLA-A2 individuals.

Chao Wu1, Damien Zanker, Sophie Valkenburg, Bee Tan, Katherine Kedzierska, Quan Ming Zou, Peter C Doherty, Weisan Chen.   

Abstract

Immunodominant T-cell responses are important for virus clearance. However, the identification of immunodominant T-cell peptide + HLA glycoprotein epitopes has been hindered by the extent of HLA polymorphism and the limitations of predictive algorithms. A simple, systematic approach has been used here to screen for immunodominant CD8(+) T-cell specificities. The analysis targeted healthy HLA-A2(+) donors to allow comparison with responses to the well-studied influenza matrix protein 1 epitope. Although influenza matrix protein 1 was consistently detected in all individual samples in our study, the response to this epitope was only immunodominant in three of eight, whereas for the other five, prominent CD8(+) T-cell responses tended to focus on various peptides from the influenza nucleoprotein that were not presented by HLA-A2. Importantly, with the four immunodominant T-cell epitopes identified here, only one would have been detected by the current prediction programs. The other three peptides would have been either considered too long or classified as not containing typical HLA binding motifs. Our data stress the importance of systematic analysis for discovering HLA-dependent, immunodominant CD8(+) T-cell epitopes derived from viruses and tumors. Focusing on HLA-A2 and predictive algorithms may be too limiting as we seek to develop targeted immunotherapy and vaccine strategies that depend on T cell-mediated immunity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21562214      PMCID: PMC3107317          DOI: 10.1073/pnas.1105624108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Have we cut ourselves too short in mapping CTL epitopes?

Authors:  Scott R Burrows; Jamie Rossjohn; James McCluskey
Journal:  Trends Immunol       Date:  2005-11-16       Impact factor: 16.687

2.  Ab and T cell epitopes of influenza A virus, knowledge and opportunities.

Authors:  Huynh-Hoa Bui; Bjoern Peters; Erika Assarsson; Innocent Mbawuike; Alessandro Sette
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-02       Impact factor: 11.205

3.  T cell responses are better correlates of vaccine protection in the elderly.

Authors:  Janet E McElhaney; Dongxu Xie; W David Hager; Mary Beth Barry; Yazhen Wang; Alison Kleppinger; Catherine Ewen; Kevin P Kane; R Chris Bleackley
Journal:  J Immunol       Date:  2006-05-15       Impact factor: 5.422

4.  Analysis of A47, an immunoprevalent protein of vaccinia virus, leads to a reevaluation of the total antiviral CD8+ T cell response.

Authors:  Tracy J Yuen; Inge E A Flesch; Natasha A Hollett; Bianca M Dobson; Tiffany A Russell; Aude M Fahrer; David C Tscharke
Journal:  J Virol       Date:  2010-07-28       Impact factor: 5.103

5.  A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen: implications for cancer vaccine design.

Authors:  Lisa M Ebert; Yu Chih Liu; Craig S Clements; Neil C Robson; Heather M Jackson; Jessica L Markby; Nektaria Dimopoulos; Bee Shin Tan; Immanuel F Luescher; Ian D Davis; Jamie Rossjohn; Jonathan Cebon; Anthony W Purcell; Weisan Chen
Journal:  Cancer Res       Date:  2009-01-27       Impact factor: 12.701

6.  Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus.

Authors:  J H C M Kreijtz; G de Mutsert; C A van Baalen; R A M Fouchier; A D M E Osterhaus; G F Rimmelzwaan
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

7.  Dominant human CD8 T cell clonotypes persist simultaneously as memory and effector cells in memory phase.

Authors:  Cédric Touvrey; Laurent Derré; Estelle Devevre; Patricia Corthesy; Pedro Romero; Nathalie Rufer; Daniel E Speiser
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

8.  Influenza virus CTL epitopes, remarkably conserved and remarkably variable.

Authors:  Guus F Rimmelzwaan; Joost H C M Kreijtz; Rogier Bodewes; Ron A M Fouchier; Albert D M E Osterhaus
Journal:  Vaccine       Date:  2009-10-23       Impact factor: 3.641

9.  Immunomic analysis of the repertoire of T-cell specificities for influenza A virus in humans.

Authors:  Erika Assarsson; Huynh-Hoa Bui; John Sidney; Qing Zhang; Jean Glenn; Carla Oseroff; Innocent N Mbawuike; Jeff Alexander; Mark J Newman; Howard Grey; Alessandro Sette
Journal:  J Virol       Date:  2008-10-08       Impact factor: 5.103

10.  HLA class I molecules consistently present internal influenza epitopes.

Authors:  Angela Wahl; Fredda Schafer; Wilfried Bardet; Rico Buchli; Gillian M Air; William H Hildebrand
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-02       Impact factor: 11.205

View more
  45 in total

1.  Predictions versus high-throughput experiments in T-cell epitope discovery: competition or synergy?

Authors:  Claus Lundegaard; Ole Lund; Morten Nielsen
Journal:  Expert Rev Vaccines       Date:  2012-01       Impact factor: 5.217

2.  Promiscuous binding of extracellular peptides to cell surface class I MHC protein.

Authors:  Herman N Eisen; Xun Helen Hou; Chase Shen; Kaidi Wang; Varsha Keelara Tanguturi; Crysela Smith; Katerina Kozyrytska; Lakshmi Nambiar; Carol A McKinley; Jianzhu Chen; Richard J Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-07       Impact factor: 11.205

Review 3.  Progress on adenovirus-vectored universal influenza vaccines.

Authors:  Kui Xiang; Guan Ying; Zhou Yan; Yan Shanshan; Zhang Lei; Li Hongjun; Sun Maosheng
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

4.  A Lipid/DNA Adjuvant-Inactivated Influenza Virus Vaccine Protects Rhesus Macaques From Uncontrolled Virus Replication After Heterosubtypic Influenza A Virus Challenge.

Authors:  Timothy D Carroll; Sinthujan Jegaskanda; Shannon R Matzinger; Linda Fritts; Michael B McChesney; Stephen J Kent; Jeffery Fairman; Christopher J Miller
Journal:  J Infect Dis       Date:  2018-08-14       Impact factor: 5.226

5.  Intranasal immunization with an epitope-based vaccine results in earlier protection, but not better protective efficacy, against Helicobacter pylori compared to subcutaneous immunization.

Authors:  Haibo Li; Jinyong Zhang; Yafei He; Bin Li; Li Chen; Weiwei Huang; Quanming Zou; Chao Wu
Journal:  Immunol Res       Date:  2015-07       Impact factor: 2.829

6.  T cells recognizing a 11mer influenza peptide complexed to H-2D(b) show promiscuity for peptide length.

Authors:  Damien Zanker; Kylie Quinn; Jason Waithman; Roleen Lata; Roger Murphy; Nicole Louise La Gruta; Weisan Chen
Journal:  Immunol Cell Biol       Date:  2015-01-06       Impact factor: 5.126

7.  Nuclear export signal and immunodominant CD8+ T cell epitope in influenza A virus matrix protein 1.

Authors:  Masanori Terajima; Francis A Ennis
Journal:  J Virol       Date:  2012-09       Impact factor: 5.103

8.  Varied Role of Ubiquitylation in Generating MHC Class I Peptide Ligands.

Authors:  Jiajie Wei; Damien Zanker; Anthony R Di Carluccio; Margery G Smelkinson; Kazuyo Takeda; Mina O Seedhom; Devin Dersh; James S Gibbs; Ning Yang; Ajit Jadhav; Weisan Chen; Jonathan W Yewdell
Journal:  J Immunol       Date:  2017-03-31       Impact factor: 5.422

Review 9.  Pushing the frontiers of T-cell vaccines: accurate measurement of human T-cell responses.

Authors:  Fadi Saade; Stacey Ann Gorski; Nikolai Petrovsky
Journal:  Expert Rev Vaccines       Date:  2012-12       Impact factor: 5.217

10.  Structures of the MHC-I molecule BF2*1501 disclose the preferred presentation of an H5N1 virus-derived epitope.

Authors:  Xiaoying Li; Lijie Zhang; Yanjie Liu; Lizhen Ma; Nianzhi Zhang; Chun Xia
Journal:  J Biol Chem       Date:  2020-03-09       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.